Core Laboratories NV
NYSE:CLB

Watchlist Manager
Core Laboratories NV Logo
Core Laboratories NV
NYSE:CLB
Watchlist
Price: 10.52 USD -1.03%
Market Cap: $485m

Wall St Price Targets

CLB Price Forecast
Based on 4 analysts

+31% Upside
from $10.52 today

CLB Analyst Rating
Based on 5 analysts

Strong buy
0 0%
Buy
1 20%
Hold
3 60%
Sell
1 20%
Strong sell
0 0%
Core Laboratories NV Competitors:
Price Targets

Revenue
Forecast

-5% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-5% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 2 years is 1%.

Gross Profit
Forecast

-9% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-9% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been -9%. The projected CAGR for the next 2 years is 3%.

Operating Income
Forecast

-12% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-12% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been -12%. The projected CAGR for the next 2 years is -2%.

Pre-Tax Income
Forecast

-13% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
-13% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -13%. The projected CAGR for the next 2 years is 1%.

Net Income
Forecast

-14% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
-14% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -14%. The projected CAGR for the next 2 years is 4%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CLB's stock price target?
Price Target
13.77 USD

According to Wall Street analysts, the average 1-year price target for CLB is 13.77 USD with a low forecast of 11.11 USD and a high forecast of 22.05 USD.

What is the Revenue forecast for Core Laboratories NV?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 2 years is 1%.

What is the Gross Profit forecast for Core Laboratories NV?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been -9%. The projected CAGR for the next 2 years is 3%.

What is the Operating Income forecast for Core Laboratories NV?
Projected CAGR
-2%

Over the last 13 years, the compound annual growth rate for Operating Income has been -12%. The projected CAGR for the next 2 years is -2%.

What is the Pre-Tax Income forecast for Core Laboratories NV?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -13%. The projected CAGR for the next 2 years is 1%.

What is the Net Income forecast for Core Laboratories NV?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Net Income has been -14%. The projected CAGR for the next 2 years is 4%.

Back to Top